Betaxolol

Product manufactured by Akorn, Inc.

Application Nr Approved Date Route Status External Links
ANDA075386 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Betaxolol Ophthalmic Solution Has Been Shown To Be Effective In Lowering Intraocular Pressure And Is Indicated In The Treatment Of Ocular Hypertension And Chronic Open-Angle Glaucoma. It May Be Used Alone Or In Combination With Other Anti-Glaucoma Drugs. In Clinical Studies, Betaxolol Ophthalmic Solution Was Safely Used To Lower Intraocular Pressure In 47 Patients With Both Glaucoma And Reactive Airway Disease Who Were Followed For A Mean Period Of 15 Months. However, Caution Should Be Used In Treating Patients With Severe Reactive Airway Disease Or A History Of Asthma.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Betaxolol Hydrochloride BETAXOLOL HYDROCHLORIDE ZINC1530567

Comments